Pharmacologic agents are commonly used to treat psychiatric diseases. These compounds, however, react differently across patients, are often followed by negative side effects and can have varied efficacy timeframes.
Active manipulation of light beams is required for a range of emerging optical technologies, including sensing, optical computing, virtual/augmented reality, dynamic holography, and computational imaging.
Stanford inventors have devised a method of multiplexing droplet reactions to analyze and identify many reactions in parallel on a single microfluidic chip using off-the-shelf flow control and valving.
Running chemotherapeutic drug screens on tumor biopsies ex vivo has the potential to increase patient survival by personally matching them to the drug which is the most effective against their particular tumor.
Engineers in Prof. James Harris' laboratory have developed a compact optics and microfluidics device to continuously monitor the hemostatic state of patients undergoing heart surgery, dialysis or other procedures.
W.E. Moerner and Adam Cohen have patented the Anti-Brownian ELectrokinetic trap (ABEL trap) which can trap, measure, and manipulate sub-micron objects (e.g. single molecules) in solution at ambient temperature.
Stanford researchers developed a method to increase microbial fermentation gas transfer – a limiting factor in the production of bio products such as polyhydroxyalkanoates (PHAs).
Stanford researchers at the Moerner Lab have designed a family of point spread functions (PSFs), the Tetrapod PSFs, for high precision three-dimensional position measurement of individual particle positions over a large, customizable depth range in optical microscopy.
Researchers at Stanford and the University of Alberta have developed fluorinated amphiphilic nanoparticles that can be used to create low-cost, stable, bio-compatible droplets for microfluidics-based digital PCR or other high-throughput screening applications.